You Position: Home > Paper
肝病合并结核病患者的抗结核药物治疗研究进展
( views:58, downloads:608 )
- Author:
- No author available
- Journal Title:
- Chinese Journal of Tuberculosis and Respiratory Diseases
- Issue:
- 10
- DOI:
- 10.3760/cma.j.issn.1001-0939.2013.10.016
- Key Word:
- No keyword available
Abstract： 肝硬化和慢性肝炎等慢性肝病是发展中国家的常见疾病,合并肝病的活动性结核病患者并不少见.对于此类患者如何进行抗结核药物治疗,目前尚缺乏一致意见,各国均未制订相关的指南或共识.笔者对这方面的研究进展进行综述,为治疗合并结核病的肝病患者提供参考依据.
- [1]杨进孙,汪长生,都郭蕾,等.抗结核药物致肝损害的相关因素分析[J].2010,(1).
- [2]Thulstrup AM,Sorensen HT,Molle I,etc.Incidence and prognosis of tuberculosis in patients with cirrhosis of the liver. A Danish nationwide population based study.[J].2000,124(2).
- [3]主编陆再英, 钟南山.内科学[M].2008.
- [4]Schenker S,Martin RR,Hoyumpa AM.Antecedent liver disease and drug toxicity.[J].1999,31(6).
- [5]N P, Thompson,M E, Caplin,M I, Hamilton,etc.Anti-tuberculosis medication and the liver: dangers and recommendations in management.[J].1995,8(8).
- [6]Belal SI,Draganov PV,Senousy BE.Hepatotoxic effects of therapies for tuberculosis.[J].2010,7(10).
- [7].Tuberculosis and liver disease: management issues[J].2012.
- [8]Chandrabose J,Swaminathan S,Padmapriyadarsini C,etc.Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.[J].2006,52(2).
- [9]Baijal R,Nagaraj K,Jain M,etc.Prevalence of tuberculosis in patients with cirrhosis of liver in western India.[J].2010,40(3).
- [10]Schenker S,Jereb JA,Nunes D,etc.An official ATS statement: hepatotoxicity of antituberculosis therapy.[J].2006,174(8).
- [11]Wauters J,Laleman W,Meersseman P,etc.Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions.[J].2011,5(4).
- [12]M A, Steele,R M, Des Prez.The role of pyrazinamide in tuberculosis chemotherapy.[J].1988,94(4).
- [13]Cho HJ,Koh WJ,Ki CS,etc.Genetic polymorphisms of NAT2 and CYP2E1 associated with antituberculosis drug-induced hepatotoxicity in Korean patients with pulmonary tuberculosis.[J].2007,87(6).
- [14]Shawcross DL,Wright GA,Stadlbauer V,etc.Ammonia impairs neutrophil phagocytic function in liver disease.[J].2008,48(4).
- [15]Lew W,Pai M,Oxlade O,etc.Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis.[J].2008,149(2).
- [16]Bonnel AR,Bunchorntavakul C,Reddy KR.Immune dysfunction and infections in patients with cirrhosis.[J].2011,9(9).
- [17]R K, Dhiman.Tuberculous peritonitis: towards a positive diagnosis.[J].2004,36(3).